Abstract:Affinity tags are frequently engineered into recombinant proteins to facilitate purification. Although this technique is powerful, removal of the tag is desired because the tag can interfere with biological activity and can potentially increase the immunogenicity of therapeutic proteins. Tag removal is complex, as it requires adding expensive protease enzymes. To overcome this limitation, split intein based affinity purification systems have been developed in which a C C -intein tag is engineered into a protein of interest for binding to a N C -intein peptide ligand fixed to a chromatographic support. Tag removal in these systems is achieved by creating an active intein-complex during protein capture, which triggers a precise self-cleavage reaction. In this work, we show applications of a new split intein system, CytivaTM ProteinSelectTM. One advantage of the new system is that the N C -intein ligand can be robustly produced and conjugated to large volumes of resin for production of gram scale proteins. SARS-CoV-2 spike protein receptor binding domain and a Bispecific T Cell Engager in this work were successfully captured on the affinity resin and scaled 10-fold. Another advantage of this system is the ability to sanitize the resin with sodium hydroxide without loosing the 10–20 g/L binding capacity. Binding studies with IL-1b and IFNAR-1 ECD showed that the resin can be regenerated and sanitized for up to 50 cycles without loosing binding capacity. Additionally, after several cycles of sanitization, binding capacity was retained for the SARS-CoV-2 spike protein receptor binding domain and a Bispecific T Cell Engager. As with other split intein systems, optimization was needed to achieve ideal expression and recovery. The N-terminal amino acid sequence of the protein of interest required engineering to enable the cleavage reaction. Additionally, ensuring the stability of the C C -intein tag was important to prevent premature cleavage or truncation. Controlling the hold time of the expression product and the prevention of protease activity prior to purification was needed. These results demonstrate the feasibility of the CytivaTM ProteinSelectTM system to be used in academic and industrial research and development laboratories for the purification of novel proteins expressed in either bacterial or mammalian systems.

A novel self-cleavable tag Zbasic–∆I-CM and its application in the soluble expression of recombinant human interleukin-15 in Escherichia coli

Molecular Dynamics Based Improvement of the Solubilizing Self-Cleavable Tag Zbasic-ΔI-CM Application in the Preparation of Recombinant Proteins in Escherichia Coli

Enhanced Production of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Escherichia Coli Using a Novel Self-Cleavable Tag System Fh8-ΔI-CM.

Streamlined Protein Expression and Purification Using Cleavable Self-Aggregating Tags

Recombinant production of medium- to large-sized peptides in Escherichia coli using a cleavable self-aggregating tag

Production of native recombinant proteins using a novel split intein affinity technology

Soluble Expression and Purification of the Functional Interleukin-30 Protein in Escherichia coli

Development of a protein-solubilizing expression method based on the synergistic action of intein ΔI-CM and the solubility enhancer elastin-like polypeptide

Expression and Purification of Tag-removed Human IL37 by Digestion on Beads in Escherichia Coli.

Clinical Manufacturing of Recombinant Human Interleukin 15. I. Production Cell Line Development and Protein Expression in E. Coli with Stop Codon Optimization.

Soluble expression, rapid purification, and characterization of human interleukin-24 (IL-24) using a MBP-SUMO dual fusion system in Escherichia coli

A novel protein purification scheme based on salt inducible self-assembling peptides

Efficient production of human interleukin-3 from Escherichia coli using protein disulfide isomerase b'a' domain

Ubiquitin-intein and SUMO2-intein fusion systems for enhanced protein production and purification.

Soluble expression of recombinant human interleukin-2 in Escherichia coli and its facile production

Soluble expression and purification of bioactive interleukin 33 in E. coli

High-level Soluble Expression, Purification, and Functional Characterization of the Recombinant Human Leukemia Inhibitory Factor: a Potential General Strategy for the Recombinant Expression of Cytokines Consisting of Four Α-Helices in a Bundle.

Expression and Efficient Purification of Tag-Cleaved Active Recombinant Human Insulin-Like Growth Factor-Ii from Escherichia Coli

Further characterization and engineering of a 11-amino acid motif for enhancing recombinant protein expression

New insight into a simple high-yielding method for the production of fully folded and functional recombinant human CCL5

A novel protein fusion partner, carbohydrate-binding module family 66, to enhance heterologous protein expression in Escherichia coli